ATE322495T1 - Verfahren zur herstellung von kristallinem n- formimidoylthienamycin-monohydrat (imipenem- monohydrat) - Google Patents

Verfahren zur herstellung von kristallinem n- formimidoylthienamycin-monohydrat (imipenem- monohydrat)

Info

Publication number
ATE322495T1
ATE322495T1 AT01980805T AT01980805T ATE322495T1 AT E322495 T1 ATE322495 T1 AT E322495T1 AT 01980805 T AT01980805 T AT 01980805T AT 01980805 T AT01980805 T AT 01980805T AT E322495 T1 ATE322495 T1 AT E322495T1
Authority
AT
Austria
Prior art keywords
monohydrate
formimidoylthienamycin
imipenem
producing crystalline
crystalline
Prior art date
Application number
AT01980805T
Other languages
English (en)
Inventor
Yatendra Kumar
Neera Tewari
Ram Chander Aryan
Bishwa Prakash Rai
Seema Ahuja
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11097114&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE322495(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Application granted granted Critical
Publication of ATE322495T1 publication Critical patent/ATE322495T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01980805T 2000-11-03 2001-11-05 Verfahren zur herstellung von kristallinem n- formimidoylthienamycin-monohydrat (imipenem- monohydrat) ATE322495T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN983DE2000 IN191798B (de) 2000-11-03 2000-11-03

Publications (1)

Publication Number Publication Date
ATE322495T1 true ATE322495T1 (de) 2006-04-15

Family

ID=11097114

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01980805T ATE322495T1 (de) 2000-11-03 2001-11-05 Verfahren zur herstellung von kristallinem n- formimidoylthienamycin-monohydrat (imipenem- monohydrat)

Country Status (19)

Country Link
US (1) US7078534B2 (de)
EP (1) EP1334105B1 (de)
JP (1) JP2004525084A (de)
KR (1) KR20030059812A (de)
CN (1) CN100445284C (de)
AT (1) ATE322495T1 (de)
AU (1) AU2002212591A1 (de)
BG (1) BG107852A (de)
CA (1) CA2427762C (de)
DE (1) DE60118593D1 (de)
DK (1) DK1334105T3 (de)
EA (1) EA006442B1 (de)
EE (1) EE200300206A (de)
ES (1) ES2261494T3 (de)
IN (1) IN191798B (de)
MX (1) MXPA03003916A (de)
PT (1) PT1334105E (de)
WO (1) WO2002036594A1 (de)
ZA (1) ZA200303338B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60233130D1 (de) * 2001-05-18 2009-09-10 Ranbaxy Lab Ltd Verfahren zur herstellung von imipenem
WO2002094773A2 (en) * 2001-05-18 2002-11-28 Ranbaxy Laboratories Limited Process for the isolation of crystalline imipenem
KR20040044409A (ko) * 2001-05-18 2004-05-28 랜박시 래보러터리스 리미티드 비결정질의 실라스타틴 소듐의 제조 방법
EP1426376A4 (de) * 2001-08-13 2004-12-22 Eisai Co Ltd Verfahren zur herstellung von carbapenem-antibiotika
US7332600B2 (en) * 2001-11-16 2008-02-19 Ranbaxy Laboratories Limited Process for the preparation of crystalline imipenem
US6537985B1 (en) 2001-11-30 2003-03-25 Phoenix Scientific, Inc. Antibiotic formulation and a method of making this formulation
EP1692135A4 (de) * 2003-12-09 2009-02-25 Choongwae Pharma Corp Neues verfahren zur herstellung von imipenem
KR100848751B1 (ko) * 2006-11-10 2008-07-25 제일약품주식회사 이미페넴의 제조방법
KR100848752B1 (ko) * 2006-11-10 2008-07-25 제일약품주식회사 티에나마이신 용매화합물 및 그의 제조방법
WO2009047604A1 (en) * 2007-10-08 2009-04-16 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
CN108623598A (zh) * 2018-05-21 2018-10-09 重庆天地药业有限责任公司 一种亚胺培南中间体及亚胺培南的制备方法
CN111413427A (zh) * 2020-04-08 2020-07-14 苏州和合医学检验有限公司 超滤前处理高效液相色谱测定血浆中亚胺培南含量的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194047A (en) 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
US4260543A (en) 1978-07-03 1981-04-07 Merck & Co., Inc. Crystalline N-formimidoyl thienamycin
JP3048196B2 (ja) 1991-06-20 2000-06-05 第一製薬株式会社 カルバペネム誘導体
DK0606336T3 (da) 1991-10-01 1997-04-14 Procter & Gamble Pharma Fremgangsmåde til fremstilling af antimikrobielle quinolonyllactamer
RU2070555C1 (ru) 1992-09-09 1996-12-20 Санкио Компани Лимитед Способ получения соединения пенема или карбапенема и соединение карбапенема
US5245069A (en) * 1992-10-27 1993-09-14 Merck & Co., Inc. Process for the preparation of bis(aryl)-phosphorohalidates
US5872250A (en) * 1997-07-30 1999-02-16 Merck & Co., Inc. Process for synthesizing carbapenem antibiotics

Also Published As

Publication number Publication date
EP1334105B1 (de) 2006-04-05
DE60118593D1 (de) 2006-05-18
IN191798B (de) 2004-01-03
CN1481384A (zh) 2004-03-10
US7078534B2 (en) 2006-07-18
ES2261494T3 (es) 2006-11-16
EE200300206A (et) 2003-10-15
EA200300520A1 (ru) 2003-10-30
JP2004525084A (ja) 2004-08-19
EA006442B1 (ru) 2005-12-29
EP1334105A1 (de) 2003-08-13
CA2427762C (en) 2009-10-20
CA2427762A1 (en) 2002-05-10
ZA200303338B (en) 2004-03-09
WO2002036594A1 (en) 2002-05-10
MXPA03003916A (es) 2004-01-29
US20040054167A1 (en) 2004-03-18
PT1334105E (pt) 2006-08-31
KR20030059812A (ko) 2003-07-10
BG107852A (bg) 2004-01-30
AU2002212591A1 (en) 2002-05-15
CN100445284C (zh) 2008-12-24
DK1334105T3 (da) 2006-08-14

Similar Documents

Publication Publication Date Title
ATE322495T1 (de) Verfahren zur herstellung von kristallinem n- formimidoylthienamycin-monohydrat (imipenem- monohydrat)
ATE462429T1 (de) Verbindungen mit fungizider wirkung und verfahren zur ihrer herstellung und verwendung
ATE489365T1 (de) Verfahren und zwischenprodukte zur herstellung von (1r,2s,5s)-6,6-dimethyl-3-azabicycloä3,1,0 ühexan-2-carboxylaten oder salzen davon
ATE306252T1 (de) Verfahren zur herstellung kristalliner partikel zur inhalation
ATE410400T1 (de) Verfahren zur herstellung von c13- alkoholgemischen
ATE417036T1 (de) Verbessertes verfahren zur herstellung von 3- hydroxy-4-hydroxymethyl-pyrrolidin-verbindungen
ATE373666T1 (de) Verfahren zur reinigung eines cephalosporin- derivats
DE69911430D1 (de) Verfahren zur herstellung von 1-(1h)-benzoquinolizin-3-on derivaten
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
ATE549315T1 (de) Verfahren zur herstellung von kristallinem perindopril
DE60010682D1 (de) Verfahren zur herstellung von zwischenprodukten für pestizide
DE60109771D1 (de) Neues verfahren zur herstellung von vinyl-pyrrolidinon cephalosporin derivate
DE60233130D1 (de) Verfahren zur herstellung von imipenem
ATE370950T1 (de) Verfahren zur herstellung von (1s,4r)-cis-4-(2- amino-6-chlor-9h-purin-9-yl)-2-cyclopenten-1- methanol
DE602005013007D1 (de) Verfahren zur herstellung von lactonen
DE60107292D1 (de) Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin
DE60100148D1 (de) Verfahren zur Herstellung eines Verbindungshalbleiter-Einkristalles
ATE417826T1 (de) Verfahren zur herstellung von zwischenprodukten
ATE272038T1 (de) Verfahren zur herstellung von 2-alkyl-3- chlorphenolen
DE602004030091D1 (de) Verfahren zur reduktiven deshalogenierung
ATE502045T1 (de) Verfahren zur herstellung von perindoprilerbumin
ATE425143T1 (de) Verfahren zur herstellung von indolen
MY134151A (en) Process for the preparation of crystalline n-formimindoyl thienamycin monohydrate (imipenem monohydrate)
DE50112461D1 (de) Verfahren zur herstellung von n-substituierten hydroxylaminen und deren salzen
ATE297478T1 (de) Verfahren zur herstellung von orthocarbonsäuretrialkylestern

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1334105

Country of ref document: EP